News

Vion Pharmaceuticals has reported that the new drug application for its lead oncology therapeutic Onrigin injection has been accepted for review by the FDA. The NDA presents data

Can-Fite, an Israeli biotechnology company, has reported that, following the approval by the Israel Ministry of Health and Rabin MC Ethics Committee, a Phase I/II clinical trial with

Intuitive Surgical, a developer and marketer of robotic technologies, has reported a net income of $28.14m, or $0.72 per diluted share, for the first quarter of 2009, compared

Sud-Chemie, a specialty chemicals company headquartered in Munich, Germany signed an agreement with BASF to acquire BASF’s production site for synthesis gas (syngas) catalysts at Nanjing, China. The

Adeona Pharmaceuticals, a specialty pharmaceutical company, has entered into an agreement to acquire Colwell Clinical Laboratories, a CLIA-certified clinical laboratory and a licensed Medicare and MediCal provider. Adeona

Additionally, data assessing fibroblast growth factor receptor-2 (FGFR-2) response to an FGFR antagonist in a novel FGFR-2 driven model were also presented. According to Aveo, preclinical data demonstrated

“We must hasten our progress against cancer by conducting exciting new science, which this year’s increase in funding, in addition to anticipated funds from the American Recovery and

The Agilent SureSelect Target Enrichment system, optimized for Illumina’s widely-adopted next-generation sequencing platform, the Genome Analyzer, provides researchers with a method for efficiently resequencing specific regions of interest

Ms Langouet has degrees in computer science and physiology. Since graduation her career has been in data management, programming, data systems and validation, process and change management, compliance